SENNA PLUS  - sennosides and docusate sodium tablet 
Geri-Care Pharmaceutical Corp

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active ingredient (in each tablet)

Docusate Sodium 50 mg
Sennosides 8.6 mg

Purpose

Stool softener

Laxative

Uses

Warnings

Do not use for more than 1 week unless directed by a doctor

Ask a doctor before use if you -have abdominal  pain, nausea or vomiting -are taking mineral oil -have noticed a sudden change in bowel habits that  lasts over 2 weeks

Stop use and ask a doctor if -you have no bowel movement within 12 hours -you have rectal bleeding. these could signs of a serious condition.

if pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor

Other information

each tablet contains: calcium 7 mg

• store at room temperature

Inactive ingredients

cellulose, croscarmellose sodium, dicalcium phosphate, FD and C yellow no. 5 (tartrazine), FD and C yellow no. 6, hypromellose, magnesium silicate, magnesium stearate, mineral oil, PEG, sodium benzoate, sodium lauryl sulfate, starch, stearic acid, titanium dioxide, triacetin

Package Label


NDC 57896-455-10

GERICARE

Gentle Senna-Plus

Natural Vegetable Laxative

with Stool Softener

Standardized Senna Concentrate

COMPARE TO ACTIVE INGREDIENT

IN SENOKOT-S

1000 Tablets

senna plus label

SENNA PLUS  
sennosides and docusate sodium tablet
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:57896-455
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE 
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 
MAGNESIUM SILICATE 
MAGNESIUM STEARATE 
MINERAL OIL 
POLYETHYLENE GLYCOLS 
HYPROMELLOSES 
FD&C YELLOW NO. 5 
FD&C YELLOW NO. 6 
SODIUM BENZOATE 
SODIUM LAURYL SULFATE 
STARCH, CORN 
STEARIC ACID 
TITANIUM DIOXIDE 
TRIACETIN 
Product Characteristics
ColoryellowScoreno score
ShapeROUNDSize10mm
FlavorImprint Code CPC490
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-455-01100 in 1 BOTTLE
2NDC:57896-455-0660 in 1 BOTTLE
3NDC:57896-455-101000 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33401/01/2000
Labeler - Geri-Care Pharmaceutical Corp (611196254)
Registrant - Geri-Care Pharmaceutical Corp (611196254)

Revised: 3/2013
Document Id: 26f45960-e2f7-4585-811c-dedc6f18f8d4
Set id: 29d63f54-03cd-40b4-9179-97c24db112f9
Version: 1
Effective Time: 20130306
 
Geri-Care Pharmaceutical Corp